Loading stock…

Core Scientific, Inc. (CORZ) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Core Scientific, Inc.

CORZMarket cap $4.94BPrice $15.4

Country🇺🇸United States

SectorTechnology

IndustrySoftware

Runs massive data centers packed with high-performance computing power, originally built for bitcoin mining but now increasingly rented out for AI workloads. Pivoted hard after crypto's crash, betting its energy-hungry infrastructure is worth more feeding algorithms than mining coins.

In Bastion Portfolios?

52W Return-19%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-21%1

Revenue Forecast

Rev CAGR (1y)+107%10

Rev CAGR (3y)+73%10

Rev CAGR (5y)+61%10

Earnings Forecast

EPS Growth Y+1Loss1

EPS Growth Y+20%5

EPS Growth Y+3Loss1

Quality

Margins

EBIT Margin-32%1

Net Income Margin-325%1

Free Cash Flow Margin-218%1

Debt

Net Debt/EBITDAna–

Efficiency

ROEna–

ROA-40%1

Earnings Stabilityna–

GEAR+VERY WEAK8

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)na–

P/E Ratio (Forward 3y)na–

P/BVna–

EV Multiples

EV/EBITDA Fwd351

EV/EBIT Fwdna–

Yield

Free Cash Flow Yield-19.4%1

Dividend Yieldna–

Momentum

Short term

1 month return-15%1

3 month return-35%1

YTD return+5%6

Mid term

Price vs 52wHigh50%1

1 year return-15%3

Long term

3 year return+347%10

5 year return+347%10

Risk Shield

Price Risk

Beta2.61

Volatility71%1

Free Cash Flow

Free Cash Flow Margin-218%1

Free Cash Flow Yield-19.4%1

Quality

ROCE-7%1

Earnings Stabilityna–

Net Debt/EBITDAna–

02Growth

Is it actually growing, and how fast?

CORZCore Scientific

Revenue FY25$319M

GROWTH RATING↗

STRONG80 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-21%1

Revenue, next 1Y+107%10

Revenue, next 3Y, CAGR+73%10

Revenue, next 5Y, CAGR+61%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28ELoss1

GROWTH ASSESSMENT

STRENGTHS

It out-grows 80% of companies worldwide.

Revenue is set to grow 73%/yr over the next 3 years, ahead of most of the market.10/10

After shrinking over the last 3 years, revenue is set to grow 73%/yr from here.

The runway holds up: revenue is set to grow 61%/yr over five years.10/10

WATCH

None flagged.

WEAKNESSES

Revenue fell 21%/yr over the last 3 years, behind 90% of companies worldwide.1/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that's turning around. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK24 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-15%1

3-month return-35%1

YTD return+5%6

MID & LONG-TERM▾SCORE

% of 52-week high50%1

1-year return-15%3

3-year return+347%10

5-year return+347%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +347% over three years and +347% over five, ahead of 90% of the market.

WATCH

Returns sit at the market level so far this year (+5%).

WEAKNESSES

It's down 15% over the past year, now 50% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-15%) and over three months (-35%).

BOTTOM LINE

Outperformer in a Drawdown

A proven multi-year compounder now in a meaningful pullback well below its 52-week high. This is the classic fork: either a buy-the-dip in an intact uptrend, or the early stage of a trend change. Wait for the short-term slide to stabilise before adding. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Core Scientific, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CORZCore Scientific

Revenue FY25$319M

GROWTH RATING↗

STRONG80 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-21%1

Revenue, next 1Y+107%10

Revenue, next 3Y, CAGR+73%10

Revenue, next 5Y, CAGR+61%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28ELoss1

GROWTH ASSESSMENT

STRENGTHS

It out-grows 80% of companies worldwide.

Revenue is set to grow 73%/yr over the next 3 years, ahead of most of the market.10/10

After shrinking over the last 3 years, revenue is set to grow 73%/yr from here.

The runway holds up: revenue is set to grow 61%/yr over five years.10/10

WATCH

None flagged.

WEAKNESSES

Revenue fell 21%/yr over the last 3 years, behind 90% of companies worldwide.1/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that's turning around. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK24 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-15%1

3-month return-35%1

YTD return+5%6

MID & LONG-TERM▾SCORE

% of 52-week high50%1

1-year return-15%3

3-year return+347%10

5-year return+347%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +347% over three years and +347% over five, ahead of 90% of the market.

WATCH

Returns sit at the market level so far this year (+5%).

WEAKNESSES

It's down 15% over the past year, now 50% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-15%) and over three months (-35%).

BOTTOM LINE

Outperformer in a Drawdown

04Value

Are you paying a fair price for it?

Stop guessing on Core Scientific, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community